BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.91M | 5.34M | 4.39M | 8.97M | 4.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.91M | 5.34M | 4.39M | 8.97M | 4.11M |
| Cost of Revenue | 7.23M | 4.12M | 3.07M | 5.73M | 2.96M |
| Gross Profit | 3.68M | 1.21M | 1.32M | 3.24M | 1.15M |
| SG&A Expenses | 1.46M | 826.30K | 892.80K | 998.30K | 588.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.10K | -- | -- | -400.00 | -- |
| Total Operating Expenses | 8.69M | 4.96M | 3.97M | 6.75M | 3.55M |
| Operating Income | 2.22M | 375.00K | 416.00K | 2.23M | 559.10K |
| Income Before Tax | 2.19M | 337.90K | 344.90K | 2.20M | 510.30K |
| Income Tax Expenses | 579.50K | 89.50K | 89.70K | 487.20K | 135.20K |
| Earnings from Continuing Operations | 1.61M | 248.30K | 255.20K | 1.71M | 375.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.61M | 248.30K | 255.20K | 1.71M | 375.10K |
| EBIT | 2.22M | 375.00K | 416.00K | 2.23M | 559.10K |
| EBITDA | 2.36M | 429.60K | 470.70K | 2.23M | 595.50K |
| EPS Basic | 0.10 | 0.02 | 0.02 | 0.11 | 0.02 |
| Normalized Basic EPS | 0.09 | 0.01 | 0.01 | 0.09 | 0.02 |
| EPS Diluted | 0.09 | 0.01 | 0.01 | 0.10 | 0.02 |
| Normalized Diluted EPS | 0.07 | 0.01 | 0.01 | 0.08 | 0.02 |
| Average Basic Shares Outstanding | 15.80M | 15.70M | 15.70M | 15.76M | 15.70M |
| Average Diluted Shares Outstanding | 18.64M | 18.52M | 18.11M | 16.89M | 17.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
